|
1
|
Strowig T, Henao-Mejia J, Elinav E and
Flavell R: Inflammasomes in health and disease. Nature.
481:278–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eisenbarth SC, Colegio OR, O'Connor W,
Sutterwala FS and Flavell RA: Crucial role for the Nalp3
inflammasome in the immunostimulatory properties of aluminium
adjuvants. Nature. 453:1122–1126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schroder K, Zhou R and Tschopp J: The
NLRP3 inflammasome: A sensor for metabolic danger? Science.
327:296–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation. Nature.
469:221–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miao H, Ou J, Ma Y, Guo F, Yang Z, Wiggins
M, Liu C, Song W, Han X, Wang M, et al: Macrophage CGI-58
deficiency activates ROS-inflammasome pathway to promote insulin
resistance in mice. Cell Rep. 7:223–235. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siebert S, Tsoukas A, Robertson J and
McInnes I: Cytokines as therapeutic targets in rheumatoid arthritis
and other inflammatory diseases. Pharmacol Rev. 67:280–309. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cunnane G, Madigan A, Murphy E, FitzGerald
O and Bresnihan B: The effects of treatment with interleukin-1
receptor antagonist on the inflamed synovial membrane in rheumatoid
arthritis. Rheumatology (Oxford). 40:62–69. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma Z, Wang B, Wang M, Sun X, Tang Y, Li M,
Li F and Li X: TL1A increased IL-6 production on fibroblast-like
synoviocytes by preferentially activating TNF receptor 2 in
rheumatoid arthritis. Cytokine. 83:92–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fontalba A, Martinez-Taboada V, Gutierrez
O, Pipaon C, Benito N, Balsa A, Blanco R and Fernandez-Luna JL:
Deficiency of the NF-kappaB inhibitor caspase activating and
recruitment domain 8 in patients with rheumatoid arthritis is
associated with disease severity. J Immunol. 179:4867–4873. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kastbom A, Verma D, Eriksson P, Skogh T,
Wingren G and Söderkvist P: Genetic variation in proteins of the
cryopyrin inflammasome influences susceptibility and severity of
rheumatoid arthritis (the Swedish TIRA project). Rheumatology
(Oxford). 47:415–417. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ben Hamad M, Cornelis F, Marzouk S,
Chabchoub G, Bahloul Z, Rebai A, Fakhfakh F, Ayadi H,
Petit-Teixeira E and Maalej A: Association study of CARD8 (p.C10X)
and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French
and Tunisian populations. Int J Immunogenet. 39:131–136. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Walle LV, Van Opdenbosch N, Jacques P,
Fossoul A, Verheugen E, Vogel P, Beyaert R, Elewaut D, Kanneganti
TD, van Loo G and Lamkanfi M: Negative regulation of the NLRP3
inflammasome by A20 protects against arthritis. Nature. 512:69–73.
2014.PubMed/NCBI
|
|
13
|
Wen H, Gris D, Lei Y, Jha S, Zhang L,
Huang MT, Brickey WJ and Ting JP: Fatty acid-induced NLRP3-ASC
inflammasome activation interferes with insulin signaling. Nat
Immunol. 12:408–415. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heneka MT, Kummer MP, Stutz A, Delekate A,
Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, et
al: NLRP3 is activated in Alzheimer's disease and contributes to
pathology in APP/PS1 mice. Nature. 493:674–678. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wree A, Eguchi A, McGeough MD, Pena CA,
Johnson CD, Canbay A, Hoffman HM and Feldstein AE: NLRP3
inflammasome activation results in hepatocyte pyroptosis, liver
inflammation, and fibrosis in mice. Hepatology. 59:898–910. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shalgi R, Lieber D, Oren M and Pilpel Y:
Global and local architecture of the mammalian
microRNA-transcription factor regulatory network. PLoS Comput Biol.
3:e1312007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ryazansky SS, Gvozdev VA and Berezikov E:
Evidence for post-transcriptional regulation of clustered microRNAs
in Drosophila. BMC Genomics. 12:3712011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krützfeldt J and Stoffel M: MicroRNAs: A
new class of regulatory genes affecting metabolism. Cell Metab.
4:9–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rayner KJ, Suárez Y, Dávalos A, Parathath
S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ and
Fernández-Hernando C: MiR-33 contributes to the regulation of
cholesterol homeostasis. Science. 328:1570–1573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Esau CC, Hussain FN, McDaniel AL, Marshall
SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, Khatsenko OG,
et al: Inhibition of miR-33a/b in non-human primates raises plasma
HDL and lowers VLDL triglycerides. Nature. 478:404–407. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karunakaran D, Thrush AB, Nguyen MA,
Richards L, Geoffrion M, Singaravelu R, Ramphos E, Shangari P,
Ouimet M, Pezacki JP, et al: Macrophage mitochondrial energy status
regulates cholesterol efflux and is enhanced by Anti-miR33 in
atherosclerosis. Circ Res. 117:266–278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ouimet M, Ediriweera HN, Gundra UM, Sheedy
FJ, Ramkhelawon B, Hutchison SB, Rinehold K, van Solingen C,
Fullerton MD, Cecchini K, et al: MicroRNA-33-dependent regulation
of macrophage metabolism directs immune cell polarization in
atherosclerosis. J Clin Invest. 125:4334–4348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eklund KK, Leirisalo-Repo M, Ranta P, Mäki
T, Kautiainen H, Hannonen P, Korpela M, Hakala M, Järvinen P and
Möttönen T: Serum IL-1beta levels are associated with the presence
of erosions in recent onset rheumatoid arthritis. Clin Exp
Rheumatol. 25:684–689. 2007.PubMed/NCBI
|
|
25
|
Ruscitti P, Cipriani P, Carubbi F,
Liakouli V, Zazzeroni F, Di Benedetto P, Berardicurti O, Alesse E
and Giacomelli R: The role of IL-1β in the bone loss during
rheumatic diseases. Mediators Inflamm. 2015:7823822015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Spiegelman BM: Transcriptional control of
mitochondrial energy metabolism through the PGC1 coactivators.
Novartis Found Symp. 287:60–63. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Haemmerle G, Moustafa T, Woelkart G,
Büttner S, Schmidt A, van de Weijer T, Hesselink M, Jaeger D,
Kienesberger PC, Zierler K, et al: ATGL-mediated fat catabolism
regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat
Med. 17:1076–1085. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen FY, Zhou J, Guo N, Ma WG, Huang X,
Wang H and Yuan ZY: Curcumin retunes cholesterol transport
homeostasis and inflammation response in M1 macrophage to prevent
atherosclerosis. Biochem Biophys Res Commun. 467:872–878. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chan KL, Pillon NJ, Sivaloganathan DM,
Costford SR, Liu Z, Théret M, Chazaud B and Klip A: Palmitoleate
reverses high fat-induced proinflammatory macrophage polarization
via AMP-activated protein kinase (AMPK). J Biol Chem.
290:16979–16988. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ho PC, Chang KC, Chuang YS and Wei LN:
Cholesterol regulation of receptor-interacting protein 140 via
microRNA-33 in inflammatory cytokine production. FASEB J.
25:1758–1766. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choulaki C, Papadaki G, Repa A, Kampouraki
E, Kambas K, Ritis K, Bertsias G, Boumpas DT and Sidiropoulos P:
Enhanced activity of NLRP3 inflammasome in peripheral blood cells
of patients with active rheumatoid arthritis. Arthritis Res Ther.
17:2572015. View Article : Google Scholar : PubMed/NCBI
|
